Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
Uttar Pradesh is almost certain to get another week for the Special Intensive Revision (SIR) of t
The family of Gopal Mukherjee alias Gopal Patha, who played an important role in protecting Hindu
The constituent parties of the Congress-led opposition alliance 'India Bloc' on Wednesday walked
At a time when Ashwin was at the peak of his career, he decided to retire from international cric
Punjab Kings and Royal Challengers Bangalore (RCB) teams would like to maintain the momentum of t
Social media was filled with memes after Suryakumar Yadav and Rinku Singh became heroes with the
Salman Khan has taken a break from hosting "Bigg Boss 19" and embarked on the Dabangg Tour. Rohit
After the murder of NCP leader Baba Siddiqui in broad daylight, Salman Khan's security has been t
The Asia Cup 2025 will start on September 9, and the Indian team has not been announced yet. It i
One country-one election bill will be presented in Lok Sabha today, BJP issued a whip to MPs
The Constitution (129th Amendment) Bill for 'One Nation One Election' is going to be introduced i
